| Company News |
Cephalon Announces Chairman and CEO to Take Medical Leave of Absence Cephalon
(August 25, 2010)
|
Event - Painful wait for ProStrakan on Abstral
(August 16, 2010)
|
Daily Market Movers (28 Jul 2010)
(July 29, 2010)
|
Daily Market Movers (27 Jul 2010)
(July 28, 2010)
|
Cephalon Reports Record Sales and Earnings in Second Quarter 2010 Cephalon
(July 27, 2010)
|
Daily Market Movers (22 Jul 2010)
(July 23, 2010)
|
Cephalon Expects Second Quarter 2010 Results to Exceed Previously Issued Guidance Cephalon
(July 21, 2010)
|
EventAnalyzer: Daily Market Movers (24 Jun 2010)
(June 25, 2010)
|
Cephalon Second Quarter 2010 Earnings Conference Call Tuesday, July 27, 2010 at 5:00 p.m. EDT Cephalon
(June 24, 2010)
|
Cephalon Partners with American Chronic Pain Association and the American Pharmacists Association to Expand National Initiative On the Safe and Appropriate Use of Prescription Medicines Cephalon
(June 23, 2010)
|
|
|
|
|
EvaluatePharma® - the premier source for pharma and biotech analysis.
Expert integration of financial and product data across historic and forecast timeframes (1986 to 2016) delivers a vast array of analytics by product, company, therapy area, EphMRA ATC code, technology, patent status, deals, license revenues and much more.
|
| Company Profile |
|
|
| Profile
|
Cephalon (CEPH), is Pennsylvania based pharmaceutical company focused on neurological, CNS and Oncology related disorders. |
| Listed or Private Company
|
Listed |
| Company Classification
|
Biotechnology |
| Company Website
|
Website
|
|
Full Company Profile Information
| EventAnalyzer - Last Key Event |
|
| Closing Price DateClosing Price Date
|
EventAnalyzer Note
|
Market Cap (US $m)
|
Change (%)
|
Change (+$m)
|
| 7/28/2010 |
27 Jul [post market]: Shares fall despite the company posting better-than-expected quarterly profits and raising its full-year forecast. |
4,333 |
-8.4% |
-397 |
|
| Top 3 Products (Worldwide Sales 2007/08) |
|
|
| RX Sales Chart |
| Cephalon
|
Data
|
Growth
|
|
2007 |
2008 |
2008 |
| Revenues By Segment
|
| Pharmaceuticals
|
| Pharmaceuticals Sales (In-depth)
|
| Rx & OTC Pharmaceuticals
|
| Prescription (Rx) Pharmaceuticals9 |
1,72710 |
1,94311 |
|
+13% |
|
|
| Therapy Area Focus in 2008 |
| Cephalon
|
|
2008 |
| WW Rx & OTC Sales By Therapy Area
|
| Main Categories
|
| Central Nervous System |
1,493 |
| Musculoskeletal |
74 |
| Oncology & Immunomodulators |
100 |
| Other Rx & OTC Pharma |
276 |
|
| EvaluatePharma® Coverage of Marketed and Pipeline Products |
|
|
|
|